Back
Ono Pharmaceutical 10K Form
Sell
14
OPHLY
Ono Pharmaceutical
Last Price:
4.79
Seasonality Move:
1.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OPHLY News And Ratings
See the #1 stock for the next 7 days that we like better than OPHLY
OPHLY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.31B |
|---|---|
| Cash Flow: | $154.13M |
| Price / Cash Flow: | 10.28 |
| Annual Sales: | $3.91 |
| Price / Book: | 1.23 |
Profitability
| EPS (TTM): | 0.62080 |
|---|---|
| Net Income (TTM): | $900.68M |
| Gross Margin: | $2.5B |
| Return on Equity: | 16.49% |
| Return on Assets: | 14.39% |
Ono Pharmaceutical Earnings Forecast
Key Ono Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 19 years for OPHLY is 75.39%.
- The Selling, General & Administrative Expenses for OPHLY have been equal to 20.01% of Gross Profit Margin.
- The Research & Development expenses have been 21.32% of Revenue.
- The Interest Expense is 0.81% of Operating Income.
- The Net Earning history of OPHLY is 25.21% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Ono Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OPHLY |
| Website: | ono.co.jp |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.95 |
| Quick Ratio: | 3.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.41 |
|---|---|
| Forward P/E Ratio: | 0 |
OPHLY Technical Analysis vs Fundamental Analysis
Sell
14
Ono Pharmaceutical (OPHLY)
is a Sell
Is Ono Pharmaceutical a Buy or a Sell?
-
Ono Pharmaceutical stock is rated a Sell
The current Ono Pharmaceutical [OPHLY] share price is $4.79. The Score for OPHLY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.